Evidence map›Paper›PMID 31180193›Full record

ArticleThe New England journal of medicine2019

Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.

Clifford J Rosen, Julie R Ingelfinger

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Adjuvant Probiotics ofFrontiers in endocrinology · 2022
    Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Diabetes type 1: Can it be treated as an autoimmune disorder?Reviews in endocrine & metabolic disorders · 2021
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Clifford J RosenFrom the Maine Medical Center Research Institute, Scarborough (C.J.R.).
Julie R IngelfingerFrom the Maine Medical Center Research Institute, Scarborough (C.J.R.).
Maine Medical Center Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Antibodies, Monoclonal, HumanizedHumansTravelAntibodies, Monoclonal, Humanizedteplizumab

Identifiers

PMID31180193
OpenAlexW2948043399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.